Insider · SEC Form 4 filer
Peter Altman
Past buys: 0 of 8 beat
Companies
Where they file as an insider
BioCardia (BCDA) President and CEO, Director Latest filing Oct 16, 2026
Track record
Did their buys beat the typical stock?
Open-market buys67
Quarters checked 6 months later8
Beat the typical stock 0 of 8
Quarters too new to check3
0 of 8 checked quarters beat the typical stock. A past record is data, not a forecast.
BioCardia (BCDA) Bought Oct 15–16, 2026 · $475 · 500 shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.
BioCardia (BCDA) Bought Jul 8–Sep 29, 2026 · $31.1K · 33,700 shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
BioCardia (BCDA) Bought Apr 20–Jun 18, 2026 · $25.1K · 25,800 shares Too new Too new. Its 6-month check uses prices as of Dec 31, 2026.
BioCardia (BCDA) Bought Jan 20–Mar 25, 2026 · $7.95K · 6,800 shares Behind typical Mar 31, 2026 $1.21 → Sep 30, 2026 $1.01 · −16.5% (typical stock +1.7%)
BioCardia (BCDA) Bought Dec 16–17, 2025 · $1.44K · 1,100 shares Behind typical Dec 31, 2025 $1.25 → Jun 30, 2026 $1.24 · −0.8% (typical stock +4.7%)
BioCardia (BCDA) Bought Aug 11–Sep 19, 2025 · $65.2K · 50,900 shares Behind typical Sep 30, 2025 $1.29 → Mar 31, 2026 $1.21 · −6.2% (typical stock −3.4%)
BioCardia (BCDA) Bought Apr 2–Jun 30, 2025 · $115K · 57,442 shares Behind typical Jun 30, 2025 $1.95 → Dec 31, 2025 $1.25 · −35.9% (typical stock +2.1%)
BioCardia (BCDA) Bought Jan 29–Mar 3, 2025 · $4.31K · 1,839 shares Behind typical Mar 31, 2025 $2.54 → Sep 30, 2025 $1.29 · −49.2% (typical stock +7.3%)
BioCardia (BCDA) Bought Nov 15–Dec 23, 2024 · $5.14K · 2,600 shares Behind typical Dec 31, 2024 $2.18 → Jun 30, 2025 $1.95 · −10.6% (typical stock −3.4%)
BioCardia (BCDA) Bought Jul 1, 2024 · $915 · 300 shares Behind typical Sep 30, 2024 $3.12 → Mar 31, 2025 $2.54 · −18.6% (typical stock −7.5%)
BioCardia (BCDA) Bought Apr 19–Jun 28, 2024 · $8.38K · 4,950 shares Behind typical Jun 30, 2024 $2.97 → Dec 31, 2024 $2.18 · −26.6% (typical stock +3.9%)
BioCardia (BCDA) Bought Feb 13–Mar 28, 2024 · $49.9K · 108,608 shares Not counted Not counted. We have no fund price for this stock on both Mar 31, 2024 and Sep 30, 2024.
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.